Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

The only update for patients with stage IV NSCLC without driver alterations is that patients who have HER2-overexpressing (IHC 3+) disease and good performance status can receive trastuzumab ...

Fifteen years later, Giancarlo is now married and has a 2-year-old son as he continues to live with stage 4 metastatic lung cancer. Over the years, the cancer has remained persistent, but each time ...

The 10-week course at Stanford last fall was fully enrolled and packed with students eager to learn from Dr. Lin's unique ...

For patients with metastatic non–small cell lung cancer (NSCLC), subcutaneous (SC ... enrolled 377 patients with newly diagnosed stage IV NSCLC without sensitizing genetic mutations.

Survival rates for metastatic lung cancer Researchers base cancer survival rates on the type of cancer, the subtype of cancer, and the stage at diagnosis ... are about 1.4% each year from 2019 ...

Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods ... Cancer Risk Declines in Old Age, Research Helps Explain Why Dec. 4, 2024 — A laboratory study provides evidence ...

is a type of skin cancer. To determine the severity of SCC, doctors use a staging system. There are five stages in total, ranging from 0 to 4. SCC stages describe the size of the primary tumor and ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...